This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Therapy by Markus Johann Bauer
Introduction
Markus Johann Bauer is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of cancer therapy through his innovative research and development efforts. His work focuses on combining various therapeutic agents to enhance the efficacy of cancer treatments.
Latest Patents
One of Markus Johann Bauer's notable patents is titled "LRP5 and PD-1 antagonist anticancer combination therapy." This invention describes anti-cancer therapies that utilize an LRP5 antagonist in conjunction with an anti-PD1 antibody. The combination aims to improve treatment outcomes for patients battling cancer.
Career Highlights
Markus Johann Bauer is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research in oncology.
Collaborations
Throughout his career, Markus has worked alongside talented colleagues such as Vittoria Zinzalla and Barbara Drobits-Handl. These collaborations have fostered an environment of innovation and have led to advancements in cancer treatment methodologies.
Conclusion
Markus Johann Bauer's contributions to cancer therapy through his patent and collaborative efforts highlight the importance of innovation in the medical field. His work continues to pave the way for more effective cancer treatments, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile